Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 201 for “"Tumor Recurrence"”.

  1. Metabolic Adaptations in Tumor Recurrence

    <p>The survival and eventual recurrence of dormant residual tumor cells following therapy is a leading cause of death in many tumor types. The metabolic properties of dormant residual tumor cells, which are thought to be quiescent or slowly proliferating, are likely distinct from those of rapidly …

    duke Repository record for Metabolic Adaptations in Tumor Recurrence (opens in a new tab)

  2. Exploring The Roles Of Long Non-Coding Rnas In Glioblastoma Tumor Recurrence And Therapy Resistance

    … most common and devastating primary CNS brain tumor with a median survival time of around 14 months. Most patients succumb to re-current disease which is often more malignant than the primary tumor and is frequently therapy resistant. There have not been significant advances in the treatment of …

    uab Repository record for Exploring The Roles Of Long Non-Coding Rnas In Glioblastoma Tumor Recurrence And Therapy Resistance (opens in a new tab)

  3. Understanding the Molecular Mechanisms that Lead to Tumor Recurrence and Acquired Therapy Resistance in Cancer

    … outcomes over the last few decades. However, tumor recurrence and acquired drug resistance continue to be detrimental for cancer patients, accounting for the majority of cancer-related deaths. Drug resistance is a common phenomenon that occurs when pharmaceutical agents are tolerated by and no …

    duke Repository record for Understanding the Molecular Mechanisms that Lead to Tumor Recurrence and Acquired Therapy Resistance in Cancer (opens in a new tab)

  4. A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up

    The selection of patients for further therapy after meningioma surgery remains a challenge. Progress has been made in this setting in selecting patients that are more likely to have an aggressive disease course by using molecular tests such as gene panel sequencing and DNA methylation profiling. …

    zurich Restricted access

  5. Differentiation of tumor recurrence from radionecrosis using 18F-FET-PET/CT after CyberKnife radiosurgery of brain tumors

    … accuracy in differentiating recurrent brain tumor from radionecrosis after radiosurgery. This explorative study analyzed this role of FET-PET in brain tumors treated by image-guided robotic stereotactic radiosurgery using CyberKnife® (CK-RS). METHOD: The study population were patients who …

    fu-berlin Repository record for Differentiation of tumor recurrence from radionecrosis using 18F-FET-PET/CT after CyberKnife radiosurgery of brain tumors (opens in a new tab)

  6. Blood Neutrophil-to-Lymphocyte Ratio predicts tumor recurrence in patients with hepatocellular carcinoma within Milan criteria after hepatectomy

    … evaluate whether NLR could predict the risk of recurrence and death for the HCC patient confirming to Milan criteria after hepatectomy. Methods: Retrospective analysis was performed on a database of HCC patients who underwent hepatectomy between March 2001 and December 2011. The cutoff value of …

    ajou Repository record for Blood Neutrophil-to-Lymphocyte Ratio predicts tumor recurrence in patients with hepatocellular carcinoma within Milan criteria after hepatectomy (opens in a new tab) Embargoed until 9999-12-31

  7. EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma

    … stemness-related markers as prognosticators of tumor recurrence and survival in patients who underwent surgical resection for HCC MATERIALS AND METHODS: A total of 262 patients were enrolled who had undergone surgical resection for HCC, with immunohistochemical staining results for EpCAM. The …

    ajou Repository record for EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma (opens in a new tab) Embargoed until 9999-12-31

  8. Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence

    … from breast cancer is principally due to tumor recurrence. Recurrent breast cancers arise from the pool of residual tumor cells, termed minimal residual disease, that survive treatment and may exist in a dormant state for up to 20 years following treatment of the primary tumor. As …

    penn Repository record for Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence (opens in a new tab)

  9. Modeling Breast Cancer Dormancy and Recurrence Following Oncogenic Pathway Inhibition

    Breast cancer recurrence is the primary cause of mortality in breast cancer, and although advances have been made in the treatment of primary breast cancer, recurrent breast cancer remains uncurable. Targeted therapy has had a major impact on survival across multiple cancer types, including breast …

    penn Repository record for Modeling Breast Cancer Dormancy and Recurrence Following Oncogenic Pathway Inhibition (opens in a new tab)

  10. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up

    … were associated with poor OS. In the analysis of tumor recurrence, 514 genomic regions with CNAs were associated with recurrence. Integrative analysis revealed that the overexpression of 16 genes including FGR (P=0.003), RELA (P=0.049), LTBP3 (P=0.050), and RIN1 (P=0.023) were significantly …

    ajou Repository record for Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up (opens in a new tab) Embargoed until 9999-12-31

  11. Prognostic significance of microvascular invasion and related microRNAs after hepatic resection for hepatocellular carcinoma

    … significance of microvascular invasion in tumor stage for hepatocellular carcinoma BACKGROUND: The presence of microvascular invasion (McVI) in hepatocellular carcinoma (HCC) has been proposed as a cause of recurrence and poor survival, although this has not been officially emphasized in …

    ajou Repository record for Prognostic significance of microvascular invasion and related microRNAs after hepatic resection for hepatocellular carcinoma (opens in a new tab) Embargoed until 9999-12-31

  12. Nuclear Basic Fibroblast Growth Factor Regulation of Triple-­Negative Breast Cancer Dormancy/Recurrence

    … within three years of treatment due to recurrent tumor growth. Developing ex vivo models for TN breast cancer recurrence and defining responsible molecules will be crucial to developing effective combination therapies for TN breast cancer patients. We have developed an in vitro model of TN breast …

    duke Repository record for Nuclear Basic Fibroblast Growth Factor Regulation of Triple-­Negative Breast Cancer Dormancy/Recurrence (opens in a new tab)

  13. Resultados de la cirugía laparoscópica comparada con la cirugía abierta en el cáncer colorrectal. Revisión sistemática

    … mortality (RR 0.94 95% CI 0.8, 1.11) or greater tumor recurrence (RR 0.74 95% CI 0.40, 1.37).) Compared with open surgery. Laparoscopic surgery reduces the need for blood transfusions and hospitalization time. Conclusion Laparoscopic surgery shows similar results in terms of mortality and tumor …

    rosario Repository record for Resultados de la cirugía laparoscópica comparada con la cirugía abierta en el cáncer colorrectal. Revisión sistemática (opens in a new tab)

  14. Novel Prognostic Markers and Therapeutic Targets for Glioblastoma

    … is the most common and lethal malignant brain tumor with a survival rate of 14.6 months and a tumor recurrence rate of ninety percent. Two key causes for glioblastomas grim outcome derive from the lack of applicable prognostic markers and effective therapeutic targets. By employing a loss of …

    vt Repository record for Novel Prognostic Markers and Therapeutic Targets for Glioblastoma (opens in a new tab)

Page 1 of 11